SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Uhlhaas, P. J.
Right arrow Articles by Morgan, C. J.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uhlhaas, P. J.
Right arrow Articles by Morgan, C. J.A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Drug Abuse
*Drugs and Young People
Hazardous Substances DB
*KETAMINE HYDROCHLORIDE
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Perceptual organization in ketamine users: preliminary evidence of deficits on night of drug use but not 3 days later

Peter J. Uhlhaas

Max Planck Institute for Brain Research, Frankfurt, Germany

Isobel Millard

Clinical Psychopharmacology Unit, UCL, London, UK.

Leslie Muetzelfeldt

Clinical Psychopharmacology Unit, UCL, London, UK

H. Valerie Curran

Clinical Psychopharmacology Unit, UCL, London, UK.

CeLia J.A. Morgan

Clinical Psychopharmacology Unit, UCL, London, UK, c.morgan{at}ucl.ac.uk

N-methyl-D-aspartate (NMDA)-receptor antagonists such as ketamine can induce transient schizophrenia-like symptoms and cognitive dysfunctions in healthy voLunteers similar to those observed in patients with schizophrenia. Perceptual organization deficits have been documented in schizophrenia and are thought to be related to some symptoms associated with the illness. The current study was designed to determine whether people who repeatedly self-administer ketamine would also show deficits in perceptual organization. Using a psychophysically well-controlled measure of contour integration, we compared a group of recreational users (n = 16) to a group of poly-drug using controls (n = 16). Contour integration performance was measured on the night of drug use and 3 days later when drug free. The results showed that on the night of drug use, ketamine produced a dysfunction in contour integration however, this was not present 3 days Later when drug free. Levels of dissociation were also higher in ketamine users ony on the night of drug use. These preliminary data provide some support for the role of NMDA-receptor hypofunctioning in dysfunctional coordination of cognitive activity.

Key Words: NMDA • ketamine • drug abuse • schizophrenia • chronic effects • perceptual organization

Journal of Psychopharmacology, Vol. 21, No. 3, 347-352 (2007)
DOI: 10.1177/0269881107077739


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement